4.9726
Nexentis Technologies Inc Aktie (NXTS) Neueste Nachrichten
Nexentis Technologies (NXTS) sells 311,876 shares; concurrent warrants issued - Stock Titan
NXTS Q2 2025 Earnings: Loss Deepens as Pre‑Revenue Phase ContinuesGrowth Acceleration Report - newsline.com
Nexentis Technologies Announces New Equity Financing Agreements - TipRanks
Nexentis Technologies Raises $1.25 Million in Registered Direct Offering, Issues 5-Year Warrants - TradingView
Nexentis Technologies (NXTS) prices $1.25M stock and warrant offerings - Stock Titan
NXTS Q2 2025 Earnings: Loss Per Share of -$0.18 Amidst Limited Financial DisclosureProfit Announcement - newsline.com
Nexentis Technologies Inc. (NXTS) Surges 10.69% as Bullish Momentum BuildsVolatility Surface - newsline.com
NXTS Q2 2025 Earnings: Loss Per Share Widens but Stock Surges on Strategic ProgressHealthcare Earnings Report - newsline.com
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
NXTS Q2 2025 Earnings: Net Loss of -$0.18 Per Share Triggers Double-Digit Stock DeclineEPS Surprise History - newsline.com
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
NXTS Q2 2025 Earnings: EPS Loss Narrows, Stock Surges on Operational ProgressHealthcare Earnings Report - The Legal Advocate
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential BreakoutCalendar Spread Trade - The Legal Advocate
Nexentis Expands Credit Facility Under Amended Financing Agreement - TipRanks
Nexentis Technologies Inc. Approves Amendment to A Facility Agreement - marketscreener.com
Nexentis Technologies (NASDAQ: NXTS) expands EUR 10M credit line and warrant terms - Stock Titan
Nexentis Technologies (NXTS) Surges 15.4% – Momentum Builds Above Key SupportAAII Bullish - newsline.com
Nexentis Technologies (NXTS) Gains 1.36% as Stock Tests Key Resistance Near $4.70Low Beta Factor - thelegaladvocate.com
Nexentis Technologies (NXTS) Earnings Outlook: Key Metrics for Q2 2025Retail Trader Picks - Newser
Nexentis subsidiary achieves drug discovery milestone By Investing.com - Investing.com South Africa
Nexentis Technologies says MitoCareX Bio achieves drug discovery milestone - TipRanks
Nexentis subsidiary reaches drug discovery milestone By Investing.com - Investing.com Nigeria
Nexentis subsidiary reaches drug discovery milestone - Investing.com
Nexentis subsidiary achieves drug discovery milestone - Investing.com
Nexentis develops new molecule to potentially tackle hard-to-treat cancers - Stock Titan
Nexentis Technologies (NASDAQ: NXTS) posts Q1 2026 loss, flags going concern risk - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Nexentis Technologies Inc. Announces Drug Discovery Milestone Achieved by MitoCareX Utilizing MITOLINE® Platform - Quiver Quantitative
Nexentis Technologies Announces Optimization of Hit - GlobeNewswire
Nexentis Technologies Inc. (NXTS) - Zacks Investment Research
Number of shareholders of Nexentis Technologies Inc. – NASDAQ:NXTS - TradingView
Nexentis Technologies Secures US Trademark Approval for MitoCareX Algorithm Platform MITOLINE - ChemAnalyst
Nexentis Technologies stock jumps on trademark approval - Investing.com
Nexentis subsidiary receives U.S. trademark for drug platform By Investing.com - Investing.com South Africa
Nexentis Technologies stock jumps on trademark approval By Investing.com - Investing.com Nigeria
Nexentis subsidiary receives U.S. trademark for drug platform - Investing.com
Drug discovery firm secures U.S. trademark for its MITOLINE platform - Stock Titan
Nexentis Technologies Announces U.S. Trademark Registration - GlobeNewswire
NXTS (Nexentis Technologies) falls 2.62% after Q2 2025 earnings with no consensus performance benchmarks available.FCF Yield - newser.com
Nexentis Shareholders Approve Reverse Split and Financing Flexibility - The Globe and Mail
Shareholders back Nexentis (NITO) reverse split and equity financing plans - Stock Titan
[EFFECT] Nexentis Technologies Inc. SEC Filing - Stock Titan
NXTS Price History for Nexentis Technologies Stock - Barchart.com
Nexentis Technologies (NXTS) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Nexentis Technologies Inc. (NXTS) Cash Equivalents (Quarterly) - Zacks Investment Research
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):